Lung cancer
Conditions
Interventions
Observation group:Na
Sponsors
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-80 years, no gender restriction; 2.Histologically or cytologically confirmed lung cancer; 3.At least one radiologically measurable lesion according to RECIST version 1.1;
Exclusion criteria
Exclusion criteria: 1.Diagnosed with a malignancy other than lung cancer within five years prior to the first dose; 2.Currently enrolled or planning to participate in any other clinical trials (e.g., interventional studies); 3.Presence of autoimmune diseases such as connective tissue disorders; 4.Long-term use of corticosteroids or immunosuppressive drugs; 5.Known history of allogeneic organ transplantation or allogeneic hematopoietic stem cell transplantation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Countries
China
Contacts
Public ContactHai Song
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Outcome results
None listed